{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T02:34:36Z","timestamp":1755225276659,"version":"3.43.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":26,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.rpth.2025.102909","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T11:15:26Z","timestamp":1748862926000},"page":"102909","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adenovirus vectors can infect mouse megakaryocytes \u2013 implications for vaccine-induced thrombosis\/thrombocytopenia"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8559-9603","authenticated-orcid":false,"given":"Simon","family":"Collett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Earnest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa A.","family":"Edeling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley Huey Yiing","family":"Yap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"Carrera Montoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantal","family":"Attard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ladina","family":"Di Rago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Farley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley P.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Monagle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Torresi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2025.102909_bib1","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abl8213","article-title":"ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome","volume":"7","author":"Baker","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.rpth.2025.102909_bib2","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2025.102909_bib3","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2025.102909_bib4","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0002-9343(96)00258-6","article-title":"A 14-year study of heparin-induced thrombocytopenia","volume":"101","author":"Warkentin","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.rpth.2025.102909_bib5","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199505183322003","article-title":"Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin","volume":"332","author":"Warkentin","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2025.102909_bib6","doi-asserted-by":"crossref","first-page":"8277","DOI":"10.1038\/ncomms9277","article-title":"Atomic description of the immune complex involved in heparin-induced thrombocytopenia","volume":"6","author":"Cai","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.rpth.2025.102909_bib7","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1182\/asheducation-2013.1.668","article-title":"Heparin-induced thrombocytopenia","volume":"2013","author":"Lee","year":"2013","journal-title":"Hematology"},{"key":"10.1016\/j.rpth.2025.102909_bib8","doi-asserted-by":"crossref","first-page":"e495S","DOI":"10.1378\/chest.11-2303","article-title":"Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Linkins","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.rpth.2025.102909_bib9","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1182\/blood.2021012938","article-title":"Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein","volume":"138","author":"Greinacher","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.102909_bib10","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2025.102909_bib11","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-021-03744-4","article-title":"Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia","volume":"596","author":"Huynh","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.rpth.2025.102909_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.728513","article-title":"Pathogenic mechanisms of vaccine-induced immune thrombotic thrombocytopenia in people receiving anti-COVID-19 adenoviral-based vaccines: a proposal","volume":"12","author":"Azzarone","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.rpth.2025.102909_bib13","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1111\/jth.15348","article-title":"Post-adenoviral-based COVID-19 vaccines thrombosis: a proposed mechanism","volume":"19","author":"Kadkhoda","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102909_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102662","article-title":"Mechanisms of immunothrombosis in vaccine-induced thrombotic thrombocytopenia (VITT) compared to natural SARS-CoV-2 infection","volume":"121","author":"McGonagle","year":"2021","journal-title":"J Autoimmun"},{"key":"10.1016\/j.rpth.2025.102909_bib15","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/imcb.12505","article-title":"Vaccine-induced immune thrombosis and thrombocytopenia syndrome following adenovirus-vectored severe acute respiratory syndrome coronavirus 2 vaccination: a novel hypothesis regarding mechanisms and implications for future vaccine development","volume":"99","author":"Monagle","year":"2021","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.rpth.2025.102909_bib16","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1538-7836.2006.01749.x","article-title":"Lentivirus degradation and DC-SIGN expression by human platelets and megakaryocytes","volume":"4","author":"Boukour","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102909_bib17","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1182\/blood-2014-09-598029","article-title":"Dengue virus binding and replication by platelets","volume":"126","author":"Simon","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.102909_bib18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fmed.2018.00121","article-title":"Platelets in immune response to virus and immunopathology of viral infections","volume":"5","author":"Hottz","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.rpth.2025.102909_bib19","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1182\/bloodadvances.2022009022","article-title":"Circulating SARS-CoV-2+ megakaryocytes are associated with severe viral infection in COVID-19","volume":"7","author":"Fortmann","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2025.102909_bib20","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/sctm.21-0264","article-title":"The heterogeneity of megakaryocytes and platelets and implications for ex vivo platelet generation","volume":"10","author":"Liu","year":"2021","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.rpth.2025.102909_bib21","article-title":"Characterization of cellular heterogeneity and an immune subpopulation of human megakaryocytes","volume":"8","author":"Liu","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.rpth.2025.102909_bib22","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.stem.2020.11.006","article-title":"Decoding human megakaryocyte development","volume":"28","author":"Wang","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.rpth.2025.102909_bib23","doi-asserted-by":"crossref","DOI":"10.1172\/JCI137377","article-title":"Lung megakaryocytes are immune modulatory cells","volume":"131","author":"Pariser","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rpth.2025.102909_bib24","doi-asserted-by":"crossref","first-page":"6204","DOI":"10.1182\/bloodadvances.2020002843","article-title":"Lung megakaryocytes display distinct transcriptional and phenotypic properties","volume":"4","author":"Yeung","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2025.102909_bib25","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.78662","article-title":"CXCR4high megakaryocytes regulate host-defense immunity against bacterial pathogens","volume":"11","author":"Wang","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.rpth.2025.102909_bib26","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V92.3.756","article-title":"The \u03b1-chemokine receptor CXCR4 is expressed on the megakaryocytic lineage from progenitor to platelets and modulates migration and adhesion","volume":"92","author":"Wang","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.102909_bib27","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nm973","article-title":"Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis","volume":"10","author":"Avecilla","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.rpth.2025.102909_bib28","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1182\/bloodadvances.2018021923","article-title":"Dynamins 2 and 3 control the migration of human megakaryocytes by regulating CXCR4 surface expression and ITGB1 activity","volume":"2","author":"Suraneni","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2025.102909_bib29","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.thromres.2010.06.023","article-title":"Platelet apoptosis resistance and increased CXCR4 expression in pediatric patients with chronic immune thrombocytopenic purpura","volume":"126","author":"Wang","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2025.102909_bib30","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1002\/art.27685","article-title":"Dysregulated expression of CXCR4\/CXCL12 in subsets of patients with systemic lupus erythematosus","volume":"62","author":"Wang","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rpth.2025.102909_bib31","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2025.102909_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa640","article-title":"Histological evidence of pulmonary microthrombosis and vasculitis in life-threatening respiratory virus diseases","volume":"8","author":"Dolby","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.rpth.2025.102909_bib33","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1477-9560-5-16","article-title":"Influenza infection and risk of acute pulmonary embolism","volume":"5","author":"van Wissen","year":"2007","journal-title":"Thromb J"},{"key":"10.1016\/j.rpth.2025.102909_bib34","doi-asserted-by":"crossref","first-page":"6828","DOI":"10.3390\/ijms21186828","article-title":"Adenovirus receptor expression in cancer and its multifaceted role in oncolytic adenovirus therapy","volume":"21","author":"Hensen","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.rpth.2025.102909_bib35","doi-asserted-by":"crossref","first-page":"D780","DOI":"10.1093\/nar\/gky1020","article-title":"Haemopedia RNA-seq: a database of gene expression during haematopoiesis in mice and humans","volume":"47","author":"Choi","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.rpth.2025.102909_bib36","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.stemcr.2016.07.007","article-title":"haemopedia: an expression atlas of murine hematopoietic cells","volume":"7","author":"de Graaf","year":"2016","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.rpth.2025.102909_bib37","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3389\/fimmu.2014.00649","article-title":"Platelets and infection \u2013 an emerging role of platelets in viral infection","volume":"5","author":"Assinger","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.rpth.2025.102909_bib38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fimmu.2015.00083","article-title":"The inflammatory role of platelets via their TLRs and siglec receptors","volume":"6","author":"Cognasse","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.rpth.2025.102909_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1065609","article-title":"Development of virus-like particles with inbuilt immunostimulatory properties as vaccine candidates","volume":"14","author":"Collett","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.rpth.2025.102909_bib40","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/organoids3010002","article-title":"Human nasal epithelium organoids for assessing neutralizing antibodies to a protective SARS-CoV-2 virus-like particle vaccine","volume":"3","author":"Carrera Montoya","year":"2024","journal-title":"Organoids"},{"key":"10.1016\/j.rpth.2025.102909_bib41","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1073\/pnas.1121385109","article-title":"Characterization of thrombopoietin (TPO)-responsive progenitor cells in adult mouse bone marrow with in vivo megakaryocyte and erythroid potential","volume":"109","author":"Ng","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.rpth.2025.102909_bib42","doi-asserted-by":"crossref","first-page":"5884","DOI":"10.1073\/pnas.1404354111","article-title":"Mpl expression on megakaryocytes and platelets is dispensable for thrombopoiesis but essential to prevent myeloproliferation","volume":"111","author":"Ng","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.rpth.2025.102909_bib43","article-title":"Measuring the DNA content of cells in apoptosis and at different cell-cycle stages by propidium iodide staining and flow cytometry","volume":"2016","author":"Crowley","year":"2016","journal-title":"Cold Spring Harb Protoc"},{"key":"10.1016\/j.rpth.2025.102909_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1276353","article-title":"Chemokines, molecular drivers of thromboinflammation and immunothrombosis","volume":"14","author":"Leberzammer","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.rpth.2025.102909_bib45","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/iub.2168","article-title":"Overexpressed microRNA-103a-3p inhibits acute lower-extremity deep venous thrombosis via inhibition of CXCL12","volume":"72","author":"Sun","year":"2020","journal-title":"IUBMB Life"},{"key":"10.1016\/j.rpth.2025.102909_bib46","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/bjh.12501","article-title":"Sequential administration of the high affinity CXCR4 antagonist BKT140 promotes megakaryopoiesis and platelet production","volume":"163","author":"Abraham","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2025.102909_bib49","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13059-016-0939-7","article-title":"Single-cell profiling of human megakaryocyte-erythroid progenitors identifies distinct megakaryocyte and erythroid differentiation pathways","volume":"17","author":"Psaila","year":"2016","journal-title":"Genome Biol"},{"key":"10.1016\/j.rpth.2025.102909_bib50","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1182\/blood.V97.7.2023","article-title":"Different expression of CD41 on human lymphoid and myeloid progenitors from adults and neonates","volume":"97","author":"Debili","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.102909_bib51","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature21706","article-title":"The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors","volume":"544","author":"Lefran\u00e7ais","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.rpth.2025.102909_bib52","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1182\/blood-2011-09-378174","article-title":"VEGFR1 stimulates a CXCR4-dependent translocation of megakaryocytes to the vascular niche, enhancing platelet production in mice","volume":"120","author":"Pitchford","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.102909_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100184","article-title":"Regulation of megakaryo\/thrombopoiesis by endosomal toll-like receptor 7 and 8 activation of CD34+ cells in a viral infection model","volume":"7","author":"Rodr\u00edguez","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102909_bib54","article-title":"Micro-concentration Lipopolysaccharide as a novel stimulator of megakaryocytopoiesis that synergizes with il-6 for platelet production","volume":"5","author":"Wu","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.rpth.2025.102909_bib55","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1182\/bloodadvances.2017007021","article-title":"Mature murine megakaryocytes present antigen-MHC class I molecules to T cells and transfer them to platelets","volume":"1","author":"Zufferey","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2025.102909_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.801945","article-title":"Characterization of CD41+ cells in the lymph node","volume":"13","author":"Dai","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.rpth.2025.102909_bib57","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1182\/blood-2018-09-873984","article-title":"Human megakaryocytes possess intrinsic antiviral immunity through regulated induction of IFITM3","volume":"133","author":"Campbell","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.102909_bib58","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1182\/blood-2005-03-0916","article-title":"Platelets express functional Toll-like receptor-4","volume":"106","author":"Andonegui","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.102909_bib59","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1160\/TH05-01-0009","article-title":"Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor","volume":"94","author":"Ward","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102909_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2020.104587","article-title":"Immunoinformatics approach to understand molecular interaction between multi-epitopic regions of SARS-CoV-2 spike-protein with TLR4\/MD-2 complex","volume":"85","author":"Bhattacharya","year":"2020","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.rpth.2025.102909_bib61","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1002\/jmv.25987","article-title":"In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs","volume":"92","author":"Choudhury","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.rpth.2025.102909_bib62","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41422-021-00495-9","article-title":"SARS-CoV-2 spike protein interacts with and activates TLR41","volume":"31","author":"Zhao","year":"2021","journal-title":"Cell Res"},{"key":"10.1016\/j.rpth.2025.102909_bib63","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1182\/blood-2006-06-032524","article-title":"Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance","volume":"109","author":"Othman","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.102909_bib64","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJMc2307721","article-title":"Adenovirus-associated thrombocytopenia, thrombosis, and VITT-like antibodies","volume":"389","author":"Warkentin","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2025.102909_bib65","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1056\/NEJMc2402592","article-title":"Antibody fingerprints linking adenoviral anti-PF4 disorders","volume":"390","author":"Wang","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2025.102909_bib66","doi-asserted-by":"crossref","first-page":"4866","DOI":"10.1128\/JVI.02819-06","article-title":"Adenovirus-platelet interaction in blood causes virus sequestration to the reticuloendothelial system of the liver","volume":"81","author":"Stone","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.rpth.2025.102909_bib67","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3390\/biomedicines11020451","article-title":"Immune response and molecular mechanisms of cardiovascular adverse effects of spike proteins from SARS-CoV-2 and mRNA vaccines","volume":"11","author":"Bellavite","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.rpth.2025.102909_bib68","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1134\/S0006297921030032","article-title":"Free SARS-CoV-2 spike protein S1 particles may play a role in the pathogenesis of COVID-19 infection","volume":"86","author":"Letarov","year":"2021","journal-title":"Biochemistry (Mosc)"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S247503792500233X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S247503792500233X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T08:39:43Z","timestamp":1755074383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S247503792500233X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S247503792500233X"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2025.102909","relation":{},"ISSN":["2475-0379"],"issn-type":[{"type":"print","value":"2475-0379"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adenovirus vectors can infect mouse megakaryocytes \u2013 implications for vaccine-induced thrombosis\/thrombocytopenia","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2025.102909","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"102909"}}